Publication: Pharmacokinetics and penetration of sitafloxacin into alveolar epithelial lining fluid in critically ill Thai patients with pneumonia
| dc.contributor.author | Paiboonvong T. | |
| dc.contributor.author | Nosoongnoen W. | |
| dc.contributor.author | Sathirakul K. | |
| dc.contributor.author | Tangsujaritvijit V. | |
| dc.contributor.author | Kaemapairoj J. | |
| dc.contributor.author | Tragulpiankit P. | |
| dc.contributor.author | Montakantikul P. | |
| dc.date.accessioned | 2021-04-05T03:04:26Z | |
| dc.date.available | 2021-04-05T03:04:26Z | |
| dc.date.issued | 2019 | |
| dc.date.issuedBE | 2562 | |
| dc.description.abstract | Sitafloxacin showed potent activity against various respiratory pathogens. Blood and bronchoalveolar lavage (BAL) fluid samples were obtained from 12 subjects after a single oral dose of sitafloxacin 200 mg. The mean ± SD (median) maximum ratio of epithelial lining fluid (ELF) to unbound plasma concentration was 1.02 ± 0.58 (1.33). The penetration ratios based on the mean and median area under the curve from 0 to 8 h (AUC0 – 8) were 0.85 and 0.79 μg · h/ml, respectively. Sitafloxacin penetrates well into ELF in critically ill Thai patients with pneumonia. (This study has been registered in the Thai Clinical Trials Registry [TCTR] under registration no. TCTR20170222001.) Copyright © 2019 American Society for Microbiology. All Rights Reserved. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Antimicrobial Agents and Chemotherapy. Vol 63, No.10 (2019) | |
| dc.identifier.doi | 10.1128/AAC.00800-19 | |
| dc.identifier.issn | 664804 | |
| dc.identifier.other | 2-s2.0-85072588748 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/5640 | |
| dc.rights.holder | มหาวิทยาลัยศรีนครินทรวิโรฒ | |
| dc.subject.other | Sitafloxacin | |
| dc.subject.other | Antiinfective agent | |
| dc.subject.other | Quinolone derivative | |
| dc.subject.other | Sitafloxacin | |
| dc.subject.other | Adult | |
| dc.subject.other | Aged | |
| dc.subject.other | Area under the curve | |
| dc.subject.other | Article | |
| dc.subject.other | Blood sampling | |
| dc.subject.other | Clinical article | |
| dc.subject.other | Critically ill patient | |
| dc.subject.other | Drug blood level | |
| dc.subject.other | Drug penetration | |
| dc.subject.other | Elimination half-life | |
| dc.subject.other | Elimination rate constant | |
| dc.subject.other | Epithelial lining fluid | |
| dc.subject.other | Female | |
| dc.subject.other | Human | |
| dc.subject.other | Liquid | |
| dc.subject.other | Lung lavage fluid | |
| dc.subject.other | Male | |
| dc.subject.other | Oral clearance | |
| dc.subject.other | Pharmacokinetic parameters | |
| dc.subject.other | Pneumonia | |
| dc.subject.other | Priority journal | |
| dc.subject.other | Single drug dose | |
| dc.subject.other | Thai (citizen) | |
| dc.subject.other | Time to maximum plasma concentration | |
| dc.subject.other | Volume of distribution | |
| dc.subject.other | Bronchoalveolar lavage fluid | |
| dc.subject.other | Critical illness | |
| dc.subject.other | Drug effect | |
| dc.subject.other | Lung | |
| dc.subject.other | Lung alveolus macrophage | |
| dc.subject.other | Lung lavage | |
| dc.subject.other | Metabolism | |
| dc.subject.other | Microbiology | |
| dc.subject.other | Middle aged | |
| dc.subject.other | Pneumonia | |
| dc.subject.other | Procedures | |
| dc.subject.other | Respiratory mucosa | |
| dc.subject.other | Thailand | |
| dc.subject.other | Adult | |
| dc.subject.other | Aged | |
| dc.subject.other | Anti-Bacterial Agents | |
| dc.subject.other | Bronchoalveolar Lavage | |
| dc.subject.other | Bronchoalveolar Lavage Fluid | |
| dc.subject.other | Critical Illness | |
| dc.subject.other | Female | |
| dc.subject.other | Fluoroquinolones | |
| dc.subject.other | Humans | |
| dc.subject.other | Lung | |
| dc.subject.other | Macrophages, Alveolar | |
| dc.subject.other | Male | |
| dc.subject.other | Middle Aged | |
| dc.subject.other | Pneumonia | |
| dc.subject.other | Respiratory Mucosa | |
| dc.subject.other | Thailand | |
| dc.title | Pharmacokinetics and penetration of sitafloxacin into alveolar epithelial lining fluid in critically ill Thai patients with pneumonia | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072588748&doi=10.1128%2fAAC.00800-19&partnerID=40&md5=62351e29caba94e1451796b151040b0e |
